Re:WHO updates critical medicines list for radiological and ...
by adrian_b on Saturday January 28, 2023 @04:19AM
(#34556327)
K iodide (KI) is not completely shelf stable, it oxidizes slowly in air (into elemental iodine, which is unsuitable to be ingested as a iodine source for humans).
K iodate (KIO3) is completely shelf stable, but it can be unpleasant when taken in very large doses.
Re:WHO updates critical medicines list for radiological and ...
by erdewit on Saturday January 28, 2023 @09:21AM
(#34557732)
Elemental iodine in solution with iodide forms tri-iodide, which is perfectly fine to consume. This is what Lugol's solution is and it has an unlimited shelf life.
Re:WHO updates critical medicines list for radiological and ...
by adrian_b on Saturday January 28, 2023 @10:26AM
(#34558307)
It is fine to consume, but the part of the iodide that has been converted into iodine can no longer be transformed into a useful form inside the human body.
Therefore any reserve of iodide will provide a smaller dose than expected when it is too old, unless it was stored in special conditions, e.g. in nitrogen without contact with air.
- "Time of treatment initiation: DTPA should be administered as soon as possible after exposure, ideally within the first 24h. If early administration is not possible, therapy can be initiated at any time; however, the efficacy decreases substantially when radionuclides are deposited in the bone and other organs (47, 48)."
- "The optimal period of administration of stable iodine is < 24 h before and ≤ 2 h after the expected onset of exposure."